Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Oncology Information Systems
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More
-
Antineoplastic Agents
... at a CAGR of 7.1% over the analysis period 2023-2030. Chemotherapeutic Agents Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$137.9 Billion by the end ... Read More
-
Sunitinib Malate
... CAGR of 9.7% over the analysis period 2023-2030. Above 99% Purity Sunitinib Malate, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$109.0 Million by the end ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Non-Melanoma Skin Cancer
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 ... Read More
-
NDDS in Cancer Therapy
... reach US$73.2 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$67.8 ... Read More
-
Cancer Immunotherapy
... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More
-
Cancer Biomarkers
... at a CAGR of 16.8% over the analysis period 2023-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of ... Read More
-
Immunomodulators
... 5.7% over the analysis period 2023-2030. Immunosuppressants, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$209.8 Million by the end of the analysis period. Growth in ... Read More
-
Cancer Registry Software
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Standalone Software, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$116.6 Million by ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 5.9% over the analysis period 2023-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$9.1 Billion by ... Read More
-
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 ... Read More
-
Chemotherapy Induced Nausea and Vomiting Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... grow at a CAGR of around 5.4% during 2025-2034. This report on global chemotherapy induced nausea and vomiting drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and ... Read More
-
Global Therapeutic Cancer Vaccines Market Growth 2024-2030
... the Therapeutic Cancer Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Therapeutic Cancer ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global cancer diagnostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cancer ... Read More
-
Radiotheranostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... report on global radiotheranostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global radiotheranostics market by segmenting ... Read More
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
... drug delivery market is projected to reach USD 2,546.0 billion by 2029 from USD 1,949.4 billion in 2024 at a CAGR of 5.5% during the forecast period. The rapid growth in the geriatric population globally ... Read More
-
Cancer/Tumor Profiling Market Size and Forecasts (2020 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology (Next-Generation Sequencing, PCR, Immunohistochemistry, In Situ Hybridization); Application (Diagnostics, Biomarker Discovery, Personalized Medicine); and End-User (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies)
... (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies) Cancer/Tumor Profiling Market Size Estimation: As of 2020, the global cancer/tumor profiling market was valued at approximately USD 12.50 billion. It is projected to reach around ... Read More
-
Skin Cancer Treatment Drugs Companies in China
... The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other ... Read More
-
Skin Cancer Treatment Drugs Markets in China
... grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study ... Read More
-
Brain Cancer Treatment Drugs Companies in China
... The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other ... Read More
-
Brain Cancer Treatment Drugs Industry Forecasts - China Focus
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More
Research Assistance
